查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1841713

生物製藥塑膠市場－全球產業規模、佔有率、趨勢、機會和預測，按聚合物類型（聚氯乙烯、聚對苯二甲酸乙二酯、聚丙烯等）、應用、地區和競爭情況細分，2020-2030 年預測

Biopharma Plastics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Polymer Type (Polyvinyl Chloride, Polyethylene Terephthalate, Polypropylene, Others), By Application, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 186 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年生物製藥塑膠市場價值為 54.7 億美元，預計到 2030 年將達到 73.4 億美元，複合年成長率為 5.23%。

市場概況
預測期 2026-2030
2024年市場規模 54.7億美元
2030年市場規模 73.4億美元
2025-2030年複合年成長率 5.23%
成長最快的領域 生物反應器袋
最大的市場 亞太地區

全球生物製藥塑膠市場正經歷轉型期，這得益於生物製藥領域對先進材料日益成長的需求。生物製藥塑膠，包括聚乙烯、聚丙烯和聚碳酸酯等聚合物，是一次性生物處理系統、包裝、實驗室器皿和藥物傳輸系統等應用不可或缺的一部分。這些材料因其耐化學性、無菌性和耐用性而備受推崇，是確保產品安全性和有效性不可或缺的關鍵材料。隨著生物製藥公司擴大採用一次性技術來降低污染風險並提高營運靈活性，生物製藥塑膠市場發展勢頭強勁，這種轉變在後疫情時代尤為明顯，人們更加重視衛生生產規範。

生物製藥生產日益複雜，推動了市場的發展。創新的藥物輸送機制和個人化醫療需要能夠滿足嚴格監管標準的材料。生物製藥塑膠與控釋系統和保護性包裝的整合，進一步拓展了其用途，滿足了全球慢性病發病率上升和人口老化日益加劇的挑戰。這種人口趨勢，加上醫療支出的增加，正在培育強勁的需求環境。對永續解決方案的追求正在影響市場動態，利害關係人正在探索環保塑膠替代品，以符合全球環境目標。

關鍵市場促進因素

一次性生物處理系統需求不斷成長

主要市場挑戰

原物料價格波動

主要市場趨勢

轉向永續和可回收塑膠

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：干擾：衝突、流行病與貿易壁壘

第5章：全球生物製藥塑膠市場展望

  • 市場規模和預測
    • 按價值和數量
  • 市場佔有率和預測
    • 依聚合物類型（聚氯乙烯 (PVC)、聚對苯二甲酸乙二酯(PET)、聚丙烯 (PP)、其他）
    • 按應用（防護服、容器、生物反應器袋、注射器、其他）
    • 按地區
    • 按公司分類（2024 年）
  • 市場地圖
    • 按聚合物類型
    • 按應用
    • 按地區

第6章：北美生物製藥塑膠市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲生物製藥塑膠市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 西班牙
    • 義大利

第8章：亞太生物製藥塑膠市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美洲生物製藥塑膠市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲生物製藥塑膠市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 產品發布
  • 併購
  • 技術進步

第 13 章：全球生物製藥塑膠市場：SWOT 分析

第 14 章：定價分析

第 15 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 16 章：競爭格局

  • Saudi Basic Industries Corporation
  • BASF SE
  • Spectrum Plastics Group
  • Celanese Corporation
  • LyondellBasell Industries Holdings BV
  • DuPont de Nemours, Inc.
  • Tekni-Plex, Inc.
  • Solvay SA
  • Avantor, Inc.
  • Bormioli Pharma SpA

第 17 章：策略建議

第18章調查會社について,免責事項

簡介目錄
Product Code: 14963

Biopharma Plastics Market was valued at USD 5.47 Billion in 2024 and is expected to reach USD 7.34 Billion by 2030 with a CAGR of 5.23%.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 5.47 Billion
Market Size 2030USD 7.34 Billion
CAGR 2025-20305.23%
Fastest Growing SegmentBioreactor Bags
Largest MarketAsia Pacific

The global biopharma plastics market is witnessing a transformative phase, driven by the escalating demand for advanced materials in the biopharmaceutical sector. Biopharma plastics, encompassing polymers such as polyethylene, polypropylene, and polycarbonate, are integral to applications including single-use bioprocessing systems, packaging, laboratory ware, and drug delivery systems. These materials are valued for their chemical resistance, sterility, and durability, making them indispensable in ensuring product safety and efficacy. The market has gained momentum as biopharmaceutical companies increasingly adopt single-use technologies to mitigate contamination risks and enhance operational flexibility, a shift that has been particularly pronounced in the post-pandemic era with heightened focus on hygienic manufacturing practices.

The market's evolution is underpinned by the growing complexity of biopharmaceutical production, where innovative drug delivery mechanisms and personalized medicine require materials that can withstand stringent regulatory standards. The integration of biopharma plastics in controlled release systems and protective packaging has further expanded their utility, catering to the rising prevalence of chronic diseases and the aging global population. This demographic trend, coupled with increased healthcare expenditure, is fostering a robust demand environment. The push towards sustainable solutions is influencing market dynamics, with stakeholders exploring eco-friendly plastic alternatives to align with global environmental goals.

Key Market Drivers

Rising Demand for Single-Use Bioprocessing Systems

The global biopharma plastics market is significantly driven by the increasing adoption of single-use bioprocessing systems, which have revolutionized manufacturing processes in the biopharmaceutical industry. These systems, utilizing plastics such as polyethylene and polypropylene, offer a cost-effective and contamination-free alternative to traditional stainless-steel setups, aligning with the industry's focus on enhancing production efficiency and safety. The shift towards single-use technologies has been accelerated by the need to reduce cross-contamination risks, a critical concern in the production of biologics and vaccines. This trend is particularly evident in the wake of global health crises, which have underscored the importance of scalable and flexible manufacturing solutions.

The demand is further supported by the growing complexity of biopharmaceutical products, including monoclonal antibodies and gene therapies, which require sterile and disposable components. Regulatory bodies worldwide are endorsing these systems, encouraging their widespread adoption through favorable guidelines. Additionally, the reduced need for extensive cleaning and validation processes associated with single-use systems translates into lower operational costs and faster turnaround times, appealing to both large-scale manufacturers and emerging biotech firms. As the biopharma sector continues to expand its pipeline, the reliance on these plastic-based solutions is expected to grow, fuelling market expansion throughout the 2020-2030F forecast period.

Key Market Challenges

Volatility in Raw Material Prices

The biopharma plastics market faces a significant challenge due to the volatility in raw material prices, which impacts production costs and profit margins. Polymers such as polyethylene and polypropylene are derived from petrochemical sources, making their prices susceptible to fluctuations in crude oil markets. This instability creates uncertainty for manufacturers, who must navigate unpredictable cost structures while maintaining competitive pricing. The challenge is compounded by the need to source high-quality raw materials that meet stringent regulatory standards, further increasing expenses during price surges.

This volatility can disrupt supply chains, leading to delays in production and potential shortages of critical components. For small and medium-sized enterprises, the inability to absorb these cost fluctuations poses a risk to their market presence. Industry players are compelled to explore alternative sourcing strategies or invest in price stabilization measures, which may require significant capital investment. Addressing this challenge will be crucial to ensuring the market's resilience over the 2020-2030F period.

Key Market Trends

Shift Towards Sustainable and Recyclable Plastics

A prominent trend in the biopharma plastics market is the shift towards sustainable and recyclable plastics, driven by increasing environmental consciousness and regulatory pressures. Manufacturers are investing in the development of bio-based polymers and recyclable materials that maintain the necessary properties for biopharmaceutical applications, such as sterility and chemical resistance. This trend aligns with global sustainability initiatives, encouraging the adoption of lightweight plastics that reduce carbon footprints during production and disposal.

The move towards eco-friendly solutions is also influencing consumer preferences, with healthcare providers and biopharma companies seeking greener alternatives to traditional plastics. This trend is expected to gain traction over the 2020-2030F period, as innovations in material science pave the way for scalable, sustainable options that meet industry standards.

Key Market Players

  • Saudi Basic Industries Corporation
  • BASF SE
  • Spectrum Plastics Group
  • Celanese Corporation
  • LyondellBasell Industries Holdings B.V.
  • DuPont de Nemours, Inc.
  • Tekni-Plex, Inc.
  • Solvay S.A.
  • Avantor, Inc.
  • Bormioli Pharma S.p.A.

Report Scope

In this report, the Global Biopharma Plastics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biopharma Plastics Market, By Polymer Type:

  • Polyvinyl Chloride (PVC)
  • Polyethylene
  • Terephthalate (PET)
  • Polypropylene (PP)
  • Others

Biopharma Plastics Market, By Application:

  • Protective Wear
  • Containers
  • Bioreactor Bags
  • Syringes
  • Others

Biopharma Plastics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Biopharma Plastics Market.

Available Customizations:

Global Biopharma Plastics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Disruptions: Conflicts, Pandemics, and Trade Barriers

5. Global Biopharma Plastics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Polymer Type (Polyvinyl Chloride (PVC), Polyethylene Terephthalate (PET), Polypropylene (PP), Others)
    • 5.2.2. By Application (Protective Wear, Containers, Bioreactor Bags, Syringes, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map
    • 5.3.1. By Polymer Type
    • 5.3.2. By Application
    • 5.3.3. By Region

6. North America Biopharma Plastics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Polymer Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Biopharma Plastics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value & Volume
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Polymer Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Mexico Biopharma Plastics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value & Volume
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Polymer Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Canada Biopharma Plastics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value & Volume
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Polymer Type
        • 6.3.3.2.2. By Application

7. Europe Biopharma Plastics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Polymer Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Biopharma Plastics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value & Volume
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Polymer Type
        • 7.3.1.2.2. By Application
    • 7.3.2. Germany Biopharma Plastics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value & Volume
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Polymer Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Biopharma Plastics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value & Volume
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Polymer Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Spain Biopharma Plastics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value & Volume
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Polymer Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Italy Biopharma Plastics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value & Volume
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Polymer Type
        • 7.3.5.2.2. By Application

8. Asia-Pacific Biopharma Plastics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Polymer Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Biopharma Plastics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value & Volume
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Polymer Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Biopharma Plastics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value & Volume
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Polymer Type
        • 8.3.2.2.2. By Application
    • 8.3.3. South Korea Biopharma Plastics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value & Volume
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Polymer Type
        • 8.3.3.2.2. By Application
    • 8.3.4. Japan Biopharma Plastics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value & Volume
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Polymer Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Biopharma Plastics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value & Volume
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Polymer Type
        • 8.3.5.2.2. By Application

9. South America Biopharma Plastics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Polymer Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Biopharma Plastics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value & Volume
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Polymer Type
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Biopharma Plastics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value & Volume
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Polymer Type
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Biopharma Plastics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value & Volume
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Polymer Type
        • 9.3.3.2.2. By Application

10. Middle East and Africa Biopharma Plastics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Polymer Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Biopharma Plastics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value & Volume
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Polymer Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Biopharma Plastics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value & Volume
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Polymer Type
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Biopharma Plastics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value & Volume
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Polymer Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Product Launches
  • 12.2. Mergers & Acquisitions
  • 12.3. Technological Advancements

13. Global Biopharma Plastics Market: SWOT Analysis

14. Pricing Analysis

15. Porter's Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. Saudi Basic Industries Corporation
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (In Case of Listed Companies)
    • 16.1.5. Recent Developments
    • 16.1.6. SWOT Analysis
  • 16.2. BASF SE
  • 16.3. Spectrum Plastics Group
  • 16.4. Celanese Corporation
  • 16.5. LyondellBasell Industries Holdings B.V.
  • 16.6. DuPont de Nemours, Inc.
  • 16.7. Tekni-Plex, Inc.
  • 16.8. Solvay S.A.
  • 16.9. Avantor, Inc.
  • 16.10. Bormioli Pharma S.p.A.

17. Strategic Recommendations

18. About Us & Disclaimer